nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—prostate cancer	0.2	0.614	CbGaD
Sulfadiazine—CYP3A4—prostate cancer	0.126	0.386	CbGaD
Sulfadiazine—CYP2C8—Nilutamide—prostate cancer	0.0424	0.0891	CbGbCtD
Sulfadiazine—CYP2C8—Abiraterone—prostate cancer	0.0351	0.0738	CbGbCtD
Sulfadiazine—CYP2E1—Estrone—prostate cancer	0.034	0.0714	CbGbCtD
Sulfadiazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0327	0.0688	CbGbCtD
Sulfadiazine—CYP2C9—Bicalutamide—prostate cancer	0.0296	0.0621	CbGbCtD
Sulfadiazine—CYP2C9—Nilutamide—prostate cancer	0.0296	0.0621	CbGbCtD
Sulfadiazine—CYP2C8—Cabazitaxel—prostate cancer	0.026	0.0546	CbGbCtD
Sulfadiazine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0226	0.0476	CbGbCtD
Sulfadiazine—CYP2E1—Mitoxantrone—prostate cancer	0.0202	0.0425	CbGbCtD
Sulfadiazine—CYP2C9—Estrone—prostate cancer	0.0177	0.0372	CbGbCtD
Sulfadiazine—CYP3A4—Bicalutamide—prostate cancer	0.0172	0.0361	CbGbCtD
Sulfadiazine—CYP3A4—Estramustine—prostate cancer	0.016	0.0336	CbGbCtD
Sulfadiazine—CYP2C8—Estradiol—prostate cancer	0.0146	0.0307	CbGbCtD
Sulfadiazine—CYP3A4—Abiraterone—prostate cancer	0.0143	0.0299	CbGbCtD
Sulfadiazine—CYP3A4—Flutamide—prostate cancer	0.0143	0.0299	CbGbCtD
Sulfadiazine—CYP2C9—Capecitabine—prostate cancer	0.0134	0.0282	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—prostate cancer	0.0128	0.0268	CbGbCtD
Sulfadiazine—CYP3A4—Cabazitaxel—prostate cancer	0.0105	0.0221	CbGbCtD
Sulfadiazine—CYP3A4—Estrone—prostate cancer	0.0103	0.0216	CbGbCtD
Sulfadiazine—CYP2C9—Estradiol—prostate cancer	0.0102	0.0214	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—prostate cancer	0.00953	0.02	CbGbCtD
Sulfadiazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00918	0.0193	CbGbCtD
Sulfadiazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00674	0.0142	CbGbCtD
Sulfadiazine—CYP3A4—Mitoxantrone—prostate cancer	0.00613	0.0129	CbGbCtD
Sulfadiazine—CYP3A4—Estradiol—prostate cancer	0.00592	0.0124	CbGbCtD
Sulfadiazine—CYP3A4—Prednisone—prostate cancer	0.00509	0.0107	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—prostate cancer	0.00386	0.00812	CbGbCtD
Sulfadiazine—CYP3A4—Docetaxel—prostate cancer	0.00354	0.00743	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—prostate cancer	0.00264	0.00554	CbGbCtD
Sulfadiazine—Sulfamethoxazole—NAT1—prostate cancer	0.00104	0.258	CrCbGaD
Sulfadiazine—Sulfasalazine—TBXAS1—prostate cancer	0.00081	0.201	CrCbGaD
Sulfadiazine—CYP2C9—urine—prostate cancer	0.000438	0.218	CbGeAlD
Sulfadiazine—CYP2E1—urine—prostate cancer	0.000415	0.207	CbGeAlD
Sulfadiazine—CYP3A4—urine—prostate cancer	0.000334	0.166	CbGeAlD
Sulfadiazine—Sulfamethoxazole—NAT2—prostate cancer	0.000328	0.0813	CrCbGaD
Sulfadiazine—Sulfathiazole—CYP19A1—prostate cancer	0.000297	0.0737	CrCbGaD
Sulfadiazine—Dapsone—NAT2—prostate cancer	0.000256	0.0636	CrCbGaD
Sulfadiazine—Sulfasalazine—CYP3A5—prostate cancer	0.000166	0.041	CrCbGaD
Sulfadiazine—Dapsone—CYP2C18—prostate cancer	0.000163	0.0404	CrCbGaD
Sulfadiazine—Sulfaphenazole—CYP2A6—prostate cancer	0.000157	0.0389	CrCbGaD
Sulfadiazine—CYP2E1—prostate gland—prostate cancer	0.000149	0.0742	CbGeAlD
Sulfadiazine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000141	0.00128	CcSEcCtD
Sulfadiazine—Arthralgia—Estradiol—prostate cancer	0.000141	0.00127	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Goserelin—prostate cancer	0.000139	0.00126	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—prostate cancer	0.000139	0.00126	CcSEcCtD
Sulfadiazine—Leukopenia—Mitoxantrone—prostate cancer	0.000138	0.00124	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000138	0.00124	CcSEcCtD
Sulfadiazine—Urticaria—Goserelin—prostate cancer	0.000135	0.00122	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000135	0.00122	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Estradiol—prostate cancer	0.000135	0.00122	CcSEcCtD
Sulfadiazine—Body temperature increased—Goserelin—prostate cancer	0.000134	0.00121	CcSEcCtD
Sulfadiazine—Abdominal pain—Goserelin—prostate cancer	0.000134	0.00121	CcSEcCtD
Sulfadiazine—Urticaria—Conjugated Estrogens—prostate cancer	0.000134	0.00121	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Docetaxel—prostate cancer	0.000133	0.00121	CcSEcCtD
Sulfadiazine—Convulsion—Mitoxantrone—prostate cancer	0.000133	0.0012	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—prostate cancer	0.000133	0.0012	CcSEcCtD
Sulfadiazine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000133	0.0012	CcSEcCtD
Sulfadiazine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000133	0.0012	CcSEcCtD
Sulfadiazine—Stomatitis—Docetaxel—prostate cancer	0.000133	0.0012	CcSEcCtD
Sulfadiazine—Chills—Etoposide—prostate cancer	0.000132	0.00119	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—prostate cancer	0.000132	0.00119	CcSEcCtD
Sulfadiazine—Depression—Capecitabine—prostate cancer	0.000131	0.00119	CcSEcCtD
Sulfadiazine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000131	0.00119	CcSEcCtD
Sulfadiazine—Arthralgia—Mitoxantrone—prostate cancer	0.000131	0.00118	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000131	0.00118	CcSEcCtD
Sulfadiazine—Rash—Ethinyl Estradiol—prostate cancer	0.00013	0.00118	CcSEcCtD
Sulfadiazine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00013	0.00118	CcSEcCtD
Sulfadiazine—Headache—Ethinyl Estradiol—prostate cancer	0.000129	0.00117	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Capecitabine—prostate cancer	0.000129	0.00117	CcSEcCtD
Sulfadiazine—Pancreatitis—Prednisone—prostate cancer	0.000129	0.00117	CcSEcCtD
Sulfadiazine—Stomatitis—Capecitabine—prostate cancer	0.000128	0.00116	CcSEcCtD
Sulfadiazine—Agranulocytosis—Docetaxel—prostate cancer	0.000127	0.00115	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000126	0.00114	CcSEcCtD
Sulfadiazine—CYP2E1—seminal vesicle—prostate cancer	0.000126	0.0627	CbGeAlD
Sulfadiazine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000126	0.00114	CcSEcCtD
Sulfadiazine—Hypersensitivity—Goserelin—prostate cancer	0.000125	0.00113	CcSEcCtD
Sulfadiazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000124	0.00112	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—prostate cancer	0.000124	0.00112	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Agranulocytosis—Capecitabine—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Nausea—Ethinyl Estradiol—prostate cancer	0.000123	0.00111	CcSEcCtD
Sulfadiazine—Hepatitis—Docetaxel—prostate cancer	0.000122	0.0011	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—prostate cancer	0.000122	0.0011	CcSEcCtD
Sulfadiazine—Insomnia—Estradiol—prostate cancer	0.000122	0.0011	CcSEcCtD
Sulfadiazine—Dapsone—MPO—prostate cancer	0.000121	0.0301	CrCbGaD
Sulfadiazine—CYP2C8—renal system—prostate cancer	0.000121	0.0601	CbGeAlD
Sulfadiazine—Pruritus—Goserelin—prostate cancer	0.00012	0.00109	CcSEcCtD
Sulfadiazine—Anorexia—Mitoxantrone—prostate cancer	0.00012	0.00108	CcSEcCtD
Sulfadiazine—Pruritus—Conjugated Estrogens—prostate cancer	0.000119	0.00108	CcSEcCtD
Sulfadiazine—Hepatitis—Capecitabine—prostate cancer	0.000118	0.00107	CcSEcCtD
Sulfadiazine—Decreased appetite—Estradiol—prostate cancer	0.000117	0.00106	CcSEcCtD
Sulfadiazine—Depression—Prednisone—prostate cancer	0.000117	0.00106	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000117	0.00106	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Estradiol—prostate cancer	0.000116	0.00105	CcSEcCtD
Sulfadiazine—Diarrhoea—Goserelin—prostate cancer	0.000116	0.00105	CcSEcCtD
Sulfadiazine—Erythema multiforme—Docetaxel—prostate cancer	0.000115	0.00104	CcSEcCtD
Sulfadiazine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000115	0.00104	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Prednisone—prostate cancer	0.000115	0.00104	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—prostate cancer	0.000115	0.00104	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—prostate cancer	0.000114	0.00104	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000114	0.00103	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—prostate cancer	0.000114	0.00103	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000114	0.00103	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—prostate cancer	0.000113	0.00102	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—prostate cancer	0.000112	0.00101	CcSEcCtD
Sulfadiazine—Erythema multiforme—Capecitabine—prostate cancer	0.000112	0.00101	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—prostate cancer	0.000111	0.001	CcSEcCtD
Sulfadiazine—Tinnitus—Capecitabine—prostate cancer	0.00011	0.000997	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Estradiol—prostate cancer	0.00011	0.000996	CcSEcCtD
Sulfadiazine—Chills—Docetaxel—prostate cancer	0.00011	0.000991	CcSEcCtD
Sulfadiazine—Decreased appetite—Mitoxantrone—prostate cancer	0.000109	0.000987	CcSEcCtD
Sulfadiazine—Vomiting—Goserelin—prostate cancer	0.000108	0.000977	CcSEcCtD
Sulfadiazine—Dapsone—CYP3A5—prostate cancer	0.000107	0.0266	CrCbGaD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000107	0.00097	CcSEcCtD
Sulfadiazine—Rash—Goserelin—prostate cancer	0.000107	0.000969	CcSEcCtD
Sulfadiazine—Dermatitis—Goserelin—prostate cancer	0.000107	0.000968	CcSEcCtD
Sulfadiazine—Vomiting—Conjugated Estrogens—prostate cancer	0.000107	0.000968	CcSEcCtD
Sulfadiazine—Urticaria—Estradiol—prostate cancer	0.000107	0.000968	CcSEcCtD
Sulfadiazine—Abdominal pain—Estradiol—prostate cancer	0.000106	0.000963	CcSEcCtD
Sulfadiazine—Body temperature increased—Estradiol—prostate cancer	0.000106	0.000963	CcSEcCtD
Sulfadiazine—Headache—Goserelin—prostate cancer	0.000106	0.000963	CcSEcCtD
Sulfadiazine—Rash—Conjugated Estrogens—prostate cancer	0.000106	0.00096	CcSEcCtD
Sulfadiazine—Chills—Capecitabine—prostate cancer	0.000106	0.000959	CcSEcCtD
Sulfadiazine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000106	0.000959	CcSEcCtD
Sulfadiazine—Headache—Conjugated Estrogens—prostate cancer	0.000105	0.000954	CcSEcCtD
Sulfadiazine—Hallucination—Prednisone—prostate cancer	0.000105	0.000948	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—prostate cancer	0.000104	0.000944	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—prostate cancer	0.000104	0.000937	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000103	0.000928	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—prostate cancer	0.000102	0.000924	CcSEcCtD
Sulfadiazine—CYP2E1—renal system—prostate cancer	0.000102	0.0506	CbGeAlD
Sulfadiazine—Nausea—Goserelin—prostate cancer	0.000101	0.000913	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—prostate cancer	0.000101	0.000912	CcSEcCtD
Sulfadiazine—Nausea—Conjugated Estrogens—prostate cancer	0.0001	0.000904	CcSEcCtD
Sulfadiazine—CYP2E1—urethra—prostate cancer	9.99e-05	0.0497	CbGeAlD
Sulfadiazine—Urticaria—Mitoxantrone—prostate cancer	9.97e-05	0.000902	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—prostate cancer	9.95e-05	0.0009	CcSEcCtD
Sulfadiazine—Hypersensitivity—Estradiol—prostate cancer	9.92e-05	0.000897	CcSEcCtD
Sulfadiazine—Abdominal pain—Mitoxantrone—prostate cancer	9.92e-05	0.000897	CcSEcCtD
Sulfadiazine—Body temperature increased—Mitoxantrone—prostate cancer	9.92e-05	0.000897	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	9.92e-05	0.000897	CcSEcCtD
Sulfadiazine—Pruritus—Estradiol—prostate cancer	9.53e-05	0.000862	CcSEcCtD
Sulfadiazine—Leukopenia—Docetaxel—prostate cancer	9.52e-05	0.000861	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—prostate cancer	9.33e-05	0.000844	CcSEcCtD
Sulfadiazine—Vertigo—Capecitabine—prostate cancer	9.25e-05	0.000836	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mitoxantrone—prostate cancer	9.25e-05	0.000836	CcSEcCtD
Sulfadiazine—Diarrhoea—Estradiol—prostate cancer	9.22e-05	0.000833	CcSEcCtD
Sulfadiazine—Leukopenia—Capecitabine—prostate cancer	9.21e-05	0.000833	CcSEcCtD
Sulfadiazine—Convulsion—Docetaxel—prostate cancer	9.21e-05	0.000833	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	9.1e-05	0.000823	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—prostate cancer	9.07e-05	0.000821	CcSEcCtD
Sulfadiazine—Arthralgia—Docetaxel—prostate cancer	9.05e-05	0.000818	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—prostate cancer	9.01e-05	0.000815	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—prostate cancer	8.99e-05	0.000813	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—prostate cancer	8.94e-05	0.000809	CcSEcCtD
Sulfadiazine—Arthralgia—Capecitabine—prostate cancer	8.76e-05	0.000792	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Docetaxel—prostate cancer	8.68e-05	0.000785	CcSEcCtD
Sulfadiazine—Diarrhoea—Mitoxantrone—prostate cancer	8.59e-05	0.000777	CcSEcCtD
Sulfadiazine—Vomiting—Estradiol—prostate cancer	8.56e-05	0.000775	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—prostate cancer	8.56e-05	0.000774	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—prostate cancer	8.54e-05	0.000772	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Docetaxel—prostate cancer	8.49e-05	0.000768	CcSEcCtD
Sulfadiazine—Rash—Estradiol—prostate cancer	8.49e-05	0.000768	CcSEcCtD
Sulfadiazine—Dermatitis—Estradiol—prostate cancer	8.48e-05	0.000767	CcSEcCtD
Sulfadiazine—Headache—Estradiol—prostate cancer	8.44e-05	0.000763	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	8.42e-05	0.000761	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—prostate cancer	8.32e-05	0.000753	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—prostate cancer	8.29e-05	0.00075	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—prostate cancer	8.27e-05	0.000748	CcSEcCtD
Sulfadiazine—Anorexia—Docetaxel—prostate cancer	8.27e-05	0.000748	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP2E1—prostate cancer	8.27e-05	0.0205	CrCbGaD
Sulfadiazine—Abdominal pain—Etoposide—prostate cancer	8.25e-05	0.000746	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—prostate cancer	8.25e-05	0.000746	CcSEcCtD
Sulfadiazine—Vertigo—Prednisone—prostate cancer	8.24e-05	0.000745	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—prostate cancer	8.24e-05	0.000745	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Capecitabine—prostate cancer	8.22e-05	0.000744	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP2C19—prostate cancer	8.19e-05	0.0203	CrCbGaD
Sulfadiazine—CYP3A4—renal system—prostate cancer	8.18e-05	0.0407	CbGeAlD
Sulfadiazine—Anorexia—Capecitabine—prostate cancer	8.01e-05	0.000724	CcSEcCtD
Sulfadiazine—Nausea—Estradiol—prostate cancer	8e-05	0.000724	CcSEcCtD
Sulfadiazine—Vomiting—Mitoxantrone—prostate cancer	7.98e-05	0.000722	CcSEcCtD
Sulfadiazine—Convulsion—Prednisone—prostate cancer	7.94e-05	0.000718	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—prostate cancer	7.92e-05	0.000716	CcSEcCtD
Sulfadiazine—Rash—Mitoxantrone—prostate cancer	7.91e-05	0.000716	CcSEcCtD
Sulfadiazine—Dermatitis—Mitoxantrone—prostate cancer	7.91e-05	0.000715	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.9e-05	0.000715	CcSEcCtD
Sulfadiazine—Headache—Mitoxantrone—prostate cancer	7.86e-05	0.000711	CcSEcCtD
Sulfadiazine—Insomnia—Docetaxel—prostate cancer	7.85e-05	0.00071	CcSEcCtD
Sulfadiazine—CYP2C8—testis—prostate cancer	7.8e-05	0.0388	CbGeAlD
Sulfadiazine—Arthralgia—Prednisone—prostate cancer	7.8e-05	0.000706	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—prostate cancer	7.79e-05	0.000704	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—prostate cancer	7.69e-05	0.000696	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—prostate cancer	7.68e-05	0.000695	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.65e-05	0.000692	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—prostate cancer	7.62e-05	0.000689	CcSEcCtD
Sulfadiazine—Insomnia—Capecitabine—prostate cancer	7.6e-05	0.000687	CcSEcCtD
Sulfadiazine—Decreased appetite—Docetaxel—prostate cancer	7.54e-05	0.000682	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Docetaxel—prostate cancer	7.49e-05	0.000677	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Prednisone—prostate cancer	7.48e-05	0.000677	CcSEcCtD
Sulfadiazine—Nausea—Mitoxantrone—prostate cancer	7.45e-05	0.000674	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—prostate cancer	7.39e-05	0.000668	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—prostate cancer	7.39e-05	0.000668	CcSEcCtD
Sulfadiazine—Dapsone—CYP2E1—prostate cancer	7.37e-05	0.0183	CrCbGaD
Sulfadiazine—Dapsone—CYP2C19—prostate cancer	7.3e-05	0.0181	CrCbGaD
Sulfadiazine—Decreased appetite—Capecitabine—prostate cancer	7.3e-05	0.00066	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Capecitabine—prostate cancer	7.25e-05	0.000656	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—prostate cancer	7.21e-05	0.000652	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—prostate cancer	7.14e-05	0.000646	CcSEcCtD
Sulfadiazine—Anorexia—Prednisone—prostate cancer	7.13e-05	0.000645	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—prostate cancer	7.11e-05	0.000643	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Docetaxel—prostate cancer	7.09e-05	0.000642	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—prostate cancer	7.01e-05	0.0174	CrCbGaD
Sulfadiazine—Gastrointestinal pain—Capecitabine—prostate cancer	6.87e-05	0.000621	CcSEcCtD
Sulfadiazine—Abdominal pain—Docetaxel—prostate cancer	6.86e-05	0.00062	CcSEcCtD
Sulfadiazine—Body temperature increased—Docetaxel—prostate cancer	6.86e-05	0.00062	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—prostate cancer	6.84e-05	0.000618	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Prednisone—prostate cancer	6.82e-05	0.000616	CcSEcCtD
Sulfadiazine—Insomnia—Prednisone—prostate cancer	6.77e-05	0.000612	CcSEcCtD
Sulfadiazine—Urticaria—Capecitabine—prostate cancer	6.67e-05	0.000603	CcSEcCtD
Sulfadiazine—Body temperature increased—Capecitabine—prostate cancer	6.64e-05	0.000601	CcSEcCtD
Sulfadiazine—Abdominal pain—Capecitabine—prostate cancer	6.64e-05	0.000601	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—prostate cancer	6.64e-05	0.0006	CcSEcCtD
Sulfadiazine—Rash—Etoposide—prostate cancer	6.58e-05	0.000595	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—prostate cancer	6.58e-05	0.000595	CcSEcCtD
Sulfadiazine—CYP2E1—testis—prostate cancer	6.57e-05	0.0327	CbGeAlD
Sulfadiazine—Headache—Etoposide—prostate cancer	6.54e-05	0.000591	CcSEcCtD
Sulfadiazine—Decreased appetite—Prednisone—prostate cancer	6.5e-05	0.000588	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—prostate cancer	6.44e-05	0.000583	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—prostate cancer	6.42e-05	0.00058	CcSEcCtD
Sulfadiazine—Hypersensitivity—Docetaxel—prostate cancer	6.39e-05	0.000578	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—prostate cancer	6.21e-05	0.000562	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—prostate cancer	6.2e-05	0.000561	CcSEcCtD
Sulfadiazine—Hypersensitivity—Capecitabine—prostate cancer	6.19e-05	0.00056	CcSEcCtD
Sulfadiazine—Pruritus—Docetaxel—prostate cancer	6.14e-05	0.000555	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Prednisone—prostate cancer	6.12e-05	0.000553	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—prostate cancer	6.1e-05	0.000552	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—prostate cancer	5.96e-05	0.000539	CcSEcCtD
Sulfadiazine—Urticaria—Prednisone—prostate cancer	5.94e-05	0.000538	CcSEcCtD
Sulfadiazine—Pruritus—Capecitabine—prostate cancer	5.94e-05	0.000537	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—prostate cancer	5.94e-05	0.000537	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—CYP3A4—prostate cancer	5.94e-05	0.0147	CrCbGaD
Sulfadiazine—Diarrhoea—Docetaxel—prostate cancer	5.94e-05	0.000537	CcSEcCtD
Sulfadiazine—Abdominal pain—Prednisone—prostate cancer	5.91e-05	0.000535	CcSEcCtD
Sulfadiazine—Body temperature increased—Prednisone—prostate cancer	5.91e-05	0.000535	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—prostate cancer	5.85e-05	0.000529	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—prostate cancer	5.75e-05	0.00052	CcSEcCtD
Sulfadiazine—Diarrhoea—Capecitabine—prostate cancer	5.75e-05	0.00052	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—prostate cancer	5.73e-05	0.000518	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—prostate cancer	5.65e-05	0.000511	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—prostate cancer	5.58e-05	0.000504	CcSEcCtD
Sulfadiazine—Vomiting—Docetaxel—prostate cancer	5.52e-05	0.000499	CcSEcCtD
Sulfadiazine—Hypersensitivity—Prednisone—prostate cancer	5.51e-05	0.000499	CcSEcCtD
Sulfadiazine—Rash—Docetaxel—prostate cancer	5.47e-05	0.000495	CcSEcCtD
Sulfadiazine—Dermatitis—Docetaxel—prostate cancer	5.46e-05	0.000494	CcSEcCtD
Sulfadiazine—Headache—Docetaxel—prostate cancer	5.43e-05	0.000492	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—prostate cancer	5.41e-05	0.00049	CcSEcCtD
Sulfadiazine—Vomiting—Capecitabine—prostate cancer	5.34e-05	0.000483	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.33e-05	0.000482	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—prostate cancer	5.3e-05	0.000479	CcSEcCtD
Sulfadiazine—Rash—Capecitabine—prostate cancer	5.3e-05	0.000479	CcSEcCtD
Sulfadiazine—Pruritus—Prednisone—prostate cancer	5.29e-05	0.000479	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—prostate cancer	5.29e-05	0.000479	CcSEcCtD
Sulfadiazine—Dermatitis—Capecitabine—prostate cancer	5.29e-05	0.000479	CcSEcCtD
Sulfadiazine—Headache—Capecitabine—prostate cancer	5.26e-05	0.000476	CcSEcCtD
Sulfadiazine—Sulfanilamide—CYP3A4—prostate cancer	5.21e-05	0.0129	CrCbGaD
Sulfadiazine—Anorexia—Doxorubicin—prostate cancer	5.16e-05	0.000467	CcSEcCtD
Sulfadiazine—Nausea—Docetaxel—prostate cancer	5.15e-05	0.000466	CcSEcCtD
Sulfadiazine—Diarrhoea—Prednisone—prostate cancer	5.12e-05	0.000463	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—prostate cancer	5.09e-05	0.00046	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.05e-05	0.000457	CcSEcCtD
Sulfadiazine—Nausea—Capecitabine—prostate cancer	4.99e-05	0.000451	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.93e-05	0.000446	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—prostate cancer	4.9e-05	0.000443	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—prostate cancer	4.78e-05	0.000433	CcSEcCtD
Sulfadiazine—Vomiting—Prednisone—prostate cancer	4.76e-05	0.00043	CcSEcCtD
Sulfadiazine—Rash—Prednisone—prostate cancer	4.72e-05	0.000427	CcSEcCtD
Sulfadiazine—Dermatitis—Prednisone—prostate cancer	4.71e-05	0.000426	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—prostate cancer	4.71e-05	0.000426	CcSEcCtD
Sulfadiazine—Headache—Prednisone—prostate cancer	4.69e-05	0.000424	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.67e-05	0.000423	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—prostate cancer	4.65e-05	0.00042	CcSEcCtD
Sulfadiazine—Dapsone—CYP3A4—prostate cancer	4.64e-05	0.0115	CrCbGaD
Sulfadiazine—Body temperature increased—Epirubicin—prostate cancer	4.63e-05	0.000418	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—prostate cancer	4.63e-05	0.000418	CcSEcCtD
Sulfadiazine—Dapsone—PTGS2—prostate cancer	4.55e-05	0.0113	CrCbGaD
Sulfadiazine—Nausea—Prednisone—prostate cancer	4.44e-05	0.000402	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.43e-05	0.0004	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—prostate cancer	4.31e-05	0.00039	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—prostate cancer	4.3e-05	0.000389	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—prostate cancer	4.28e-05	0.000387	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—prostate cancer	4.28e-05	0.000387	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—prostate cancer	4.14e-05	0.000374	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—prostate cancer	4e-05	0.000362	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—prostate cancer	3.99e-05	0.000361	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—prostate cancer	3.83e-05	0.000346	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—prostate cancer	3.72e-05	0.000336	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—prostate cancer	3.7e-05	0.000335	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—prostate cancer	3.69e-05	0.000334	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—prostate cancer	3.69e-05	0.000333	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—prostate cancer	3.67e-05	0.000332	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—prostate cancer	3.48e-05	0.000314	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—prostate cancer	3.44e-05	0.000311	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—prostate cancer	3.41e-05	0.000309	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—prostate cancer	3.41e-05	0.000308	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—prostate cancer	3.39e-05	0.000307	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—prostate cancer	3.22e-05	0.000291	CcSEcCtD
Sulfadiazine—CYP2C9—Metabolism—GSTA3—prostate cancer	9.12e-06	0.000112	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TCN2—prostate cancer	9.12e-06	0.000112	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—P4HB—prostate cancer	8.96e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD17B1—prostate cancer	8.91e-06	0.000109	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HPGDS—prostate cancer	8.82e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2C19—prostate cancer	8.76e-06	0.000107	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC22A1—prostate cancer	8.72e-06	0.000107	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC22A3—prostate cancer	8.7e-06	0.000106	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD3B1—prostate cancer	8.7e-06	0.000106	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.62e-06	0.000105	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—prostate cancer	8.55e-06	0.000105	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ACHE—prostate cancer	8.55e-06	0.000105	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SULT2A1—prostate cancer	8.5e-06	0.000104	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2A6—prostate cancer	8.45e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.45e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MED12—prostate cancer	8.36e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TBXAS1—prostate cancer	8.35e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA4—prostate cancer	8.35e-06	0.000102	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GNG5—prostate cancer	8.29e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKR1C3—prostate cancer	8.22e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PRKACB—prostate cancer	8.18e-06	0.0001	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.16e-06	9.98e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA2—prostate cancer	8.13e-06	9.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP17A1—prostate cancer	8.1e-06	9.9e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG5—prostate cancer	8.03e-06	9.83e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SULT1A1—prostate cancer	8.03e-06	9.83e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA3—prostate cancer	7.99e-06	9.77e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—B4GALT4—prostate cancer	7.94e-06	9.71e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPGD—prostate cancer	7.94e-06	9.71e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.85e-06	9.6e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA1—prostate cancer	7.85e-06	9.6e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAT2—prostate cancer	7.76e-06	9.49e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD3B2—prostate cancer	7.76e-06	9.49e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTO1—prostate cancer	7.76e-06	9.49e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOA2—prostate cancer	7.71e-06	9.43e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HPGDS—prostate cancer	7.62e-06	9.32e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2C19—prostate cancer	7.57e-06	9.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.47e-06	9.13e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.46e-06	9.12e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLCB2—prostate cancer	7.44e-06	9.1e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2C18—prostate cancer	7.44e-06	9.1e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LRP2—prostate cancer	7.44e-06	9.1e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—prostate cancer	7.39e-06	9.04e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ACHE—prostate cancer	7.39e-06	9.04e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC5A5—prostate cancer	7.36e-06	9e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2A6—prostate cancer	7.31e-06	8.94e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—P4HB—prostate cancer	7.29e-06	8.92e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.28e-06	8.9e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.26e-06	8.88e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTAP—prostate cancer	7.26e-06	8.88e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKR1C3—prostate cancer	7.11e-06	8.69e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NQO1—prostate cancer	7.11e-06	8.69e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC22A1—prostate cancer	7.1e-06	8.68e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.08e-06	8.66e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.08e-06	8.66e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PRKACB—prostate cancer	7.07e-06	8.65e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.01e-06	8.58e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TH—prostate cancer	7e-06	8.57e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP17A1—prostate cancer	7e-06	8.56e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP3A4—prostate cancer	6.93e-06	8.48e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SULT2A1—prostate cancer	6.92e-06	8.46e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.9e-06	8.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1B1—prostate cancer	6.81e-06	8.33e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MED12—prostate cancer	6.8e-06	8.32e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACSL4—prostate cancer	6.75e-06	8.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.75e-06	8.26e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GNG5—prostate cancer	6.75e-06	8.26e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA2—prostate cancer	6.67e-06	8.15e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GGT1—prostate cancer	6.6e-06	8.07e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA3—prostate cancer	6.5e-06	7.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOA1—prostate cancer	6.5e-06	7.95e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UMPS—prostate cancer	6.47e-06	7.92e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PHGDH—prostate cancer	6.47e-06	7.92e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ARG2—prostate cancer	6.47e-06	7.92e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP19A1—prostate cancer	6.41e-06	7.84e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.39e-06	7.81e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC5A5—prostate cancer	6.36e-06	7.78e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LDHB—prostate cancer	6.35e-06	7.76e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.23e-06	7.62e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—prostate cancer	6.21e-06	7.6e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HPGDS—prostate cancer	6.2e-06	7.59e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—RXRA—prostate cancer	6.18e-06	7.56e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.16e-06	7.54e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NQO1—prostate cancer	6.14e-06	7.51e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TH—prostate cancer	6.05e-06	7.41e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA3—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TCN2—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PDHA1—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UCP3—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ACHE—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP3A4—prostate cancer	5.99e-06	7.33e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.96e-06	7.29e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—COMT—prostate cancer	5.96e-06	7.28e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2A6—prostate cancer	5.95e-06	7.27e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—prostate cancer	5.93e-06	7.25e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.92e-06	7.25e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1B1—prostate cancer	5.89e-06	7.2e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ITPR1—prostate cancer	5.83e-06	7.13e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKR1C3—prostate cancer	5.78e-06	7.08e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PRKACB—prostate cancer	5.75e-06	7.04e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.74e-06	7.02e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.74e-06	7.02e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GGT1—prostate cancer	5.7e-06	6.98e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.69e-06	6.97e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA1—prostate cancer	5.62e-06	6.87e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.62e-06	6.87e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP19A1—prostate cancer	5.54e-06	6.77e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TYMS—prostate cancer	5.51e-06	6.74e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA4—prostate cancer	5.5e-06	6.73e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.5e-06	6.73e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—prostate cancer	5.45e-06	6.66e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA2—prostate cancer	5.43e-06	6.64e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA2—prostate cancer	5.36e-06	6.56e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPL—prostate cancer	5.35e-06	6.54e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—RXRA—prostate cancer	5.34e-06	6.54e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.3e-06	6.48e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG5—prostate cancer	5.3e-06	6.48e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.2e-06	6.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.18e-06	6.33e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA1—prostate cancer	5.17e-06	6.33e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—prostate cancer	5.16e-06	6.32e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—COMT—prostate cancer	5.15e-06	6.3e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—prostate cancer	5.12e-06	6.27e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ERCC2—prostate cancer	5.12e-06	6.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAT2—prostate cancer	5.12e-06	6.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTO1—prostate cancer	5.12e-06	6.26e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.12e-06	6.26e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.06e-06	6.18e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ITPR1—prostate cancer	5.04e-06	6.17e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NQO1—prostate cancer	5e-06	6.12e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.96e-06	6.06e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TH—prostate cancer	4.93e-06	6.03e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLCB2—prostate cancer	4.91e-06	6e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LRP2—prostate cancer	4.91e-06	6e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.91e-06	6e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.9e-06	5.99e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.88e-06	5.96e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.85e-06	5.93e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—prostate cancer	4.81e-06	5.89e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—P4HB—prostate cancer	4.81e-06	5.88e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.79e-06	5.86e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TYMS—prostate cancer	4.76e-06	5.83e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARA—prostate cancer	4.72e-06	5.78e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—prostate cancer	4.71e-06	5.76e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.68e-06	5.72e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GGT1—prostate cancer	4.64e-06	5.68e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPL—prostate cancer	4.62e-06	5.65e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA1—prostate cancer	4.57e-06	5.59e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.56e-06	5.58e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.51e-06	5.51e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MED12—prostate cancer	4.49e-06	5.49e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.46e-06	5.46e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GNG5—prostate cancer	4.45e-06	5.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAV1—prostate cancer	4.44e-06	5.43e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ERCC2—prostate cancer	4.43e-06	5.41e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—RXRA—prostate cancer	4.35e-06	5.32e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA3—prostate cancer	4.29e-06	5.24e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.23e-06	5.17e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—COMT—prostate cancer	4.19e-06	5.12e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—prostate cancer	4.17e-06	5.1e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—prostate cancer	4.16e-06	5.09e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ITPR1—prostate cancer	4.1e-06	5.02e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPGDS—prostate cancer	4.09e-06	5e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARA—prostate cancer	4.08e-06	4.99e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.06e-06	4.97e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—prostate cancer	4.04e-06	4.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.03e-06	4.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACHE—prostate cancer	3.97e-06	4.85e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.97e-06	4.85e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.92e-06	4.8e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TYMS—prostate cancer	3.88e-06	4.74e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAV1—prostate cancer	3.84e-06	4.69e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—prostate cancer	3.83e-06	4.69e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—prostate cancer	3.83e-06	4.68e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.82e-06	4.67e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.79e-06	4.64e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPL—prostate cancer	3.76e-06	4.6e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.76e-06	4.59e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CREBBP—prostate cancer	3.75e-06	4.59e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.67e-06	4.48e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.63e-06	4.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ERCC2—prostate cancer	3.6e-06	4.41e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.58e-06	4.38e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.56e-06	4.35e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.5e-06	4.28e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.41e-06	4.18e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—prostate cancer	3.39e-06	4.14e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—prostate cancer	3.36e-06	4.11e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.33e-06	4.08e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARA—prostate cancer	3.32e-06	4.06e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—prostate cancer	3.31e-06	4.05e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NQO1—prostate cancer	3.3e-06	4.03e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TH—prostate cancer	3.25e-06	3.97e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CREBBP—prostate cancer	3.24e-06	3.96e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.16e-06	3.87e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAV1—prostate cancer	3.12e-06	3.82e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CB—prostate cancer	3.1e-06	3.79e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.07e-06	3.76e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—prostate cancer	3.07e-06	3.76e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GGT1—prostate cancer	3.06e-06	3.74e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA1—prostate cancer	3.02e-06	3.69e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.98e-06	3.65e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.97e-06	3.64e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—prostate cancer	2.9e-06	3.55e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—RXRA—prostate cancer	2.87e-06	3.51e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.85e-06	3.48e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COMT—prostate cancer	2.76e-06	3.38e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.75e-06	3.36e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.71e-06	3.31e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—prostate cancer	2.69e-06	3.29e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.68e-06	3.28e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTEN—prostate cancer	2.68e-06	3.28e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—prostate cancer	2.65e-06	3.25e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CREBBP—prostate cancer	2.64e-06	3.23e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TYMS—prostate cancer	2.56e-06	3.13e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—EP300—prostate cancer	2.55e-06	3.12e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.53e-06	3.09e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.5e-06	3.06e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPL—prostate cancer	2.48e-06	3.03e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.4e-06	2.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.38e-06	2.91e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—prostate cancer	2.36e-06	2.89e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTEN—prostate cancer	2.31e-06	2.83e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—prostate cancer	2.23e-06	2.73e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—EP300—prostate cancer	2.21e-06	2.7e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARA—prostate cancer	2.19e-06	2.68e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.18e-06	2.67e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—prostate cancer	2.16e-06	2.64e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAV1—prostate cancer	2.06e-06	2.52e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.89e-06	2.31e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTEN—prostate cancer	1.88e-06	2.3e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.88e-06	2.3e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—EP300—prostate cancer	1.8e-06	2.2e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—prostate cancer	1.78e-06	2.17e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.65e-06	2.02e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.63e-06	2e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—prostate cancer	1.56e-06	1.91e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—prostate cancer	1.54e-06	1.89e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.44e-06	1.76e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.42e-06	1.74e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—prostate cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTEN—prostate cancer	1.24e-06	1.52e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—EP300—prostate cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—prostate cancer	1.09e-06	1.33e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.77e-07	1.07e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—prostate cancer	7.16e-07	8.76e-06	CbGpPWpGaD
